BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22562456)

  • 1. HIF-mediated endothelial response during cancer progression.
    Evans CE; Branco-Price C; Johnson RS
    Int J Hematol; 2012 May; 95(5):471-7. PubMed ID: 22562456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic hypoxia differentially predispose lungs for metastases.
    Reiterer M; Colaço R; Emrouznejad P; Jensen A; Rundqvist H; Johnson RS; Branco C
    Sci Rep; 2019 Jul; 9(1):10246. PubMed ID: 31308473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies.
    Araos J; Sleeman JP; Garvalov BK
    Clin Exp Metastasis; 2018 Oct; 35(7):563-599. PubMed ID: 30171389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia and cancer.
    Brahimi-Horn MC; Chiche J; Pouysségur J
    J Mol Med (Berl); 2007 Dec; 85(12):1301-7. PubMed ID: 18026916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of HIF on tumour progression and dissemination.
    Unwith S; Zhao H; Hennah L; Ma D
    Int J Cancer; 2015 Jun; 136(11):2491-503. PubMed ID: 24729302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial hypoxic metabolism in carcinogenesis and dissemination: HIF-A isoforms are a NO metastatic phenomenon.
    Branco-Price C; Evans CE; Johnson RS
    Oncotarget; 2013 Dec; 4(12):2567-76. PubMed ID: 24318195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
    Brahimi-Horn C; Pouysségur J
    Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF in vascular development and tumour angiogenesis.
    Breier G; Licht AH; Nicolaus A; Klotzsche A; Wielockx B; Kirsnerova Z
    Novartis Found Symp; 2007; 283():126-33; discussion 133-8, 238-41. PubMed ID: 18300418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIFs, angiogenesis, and cancer.
    Yang Y; Sun M; Wang L; Jiao B
    J Cell Biochem; 2013 May; 114(5):967-74. PubMed ID: 23225225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.
    Mimeault M; Batra SK
    J Cell Mol Med; 2013 Jan; 17(1):30-54. PubMed ID: 23301832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hypoxia and HIFs on cancer metabolism.
    Mucaj V; Shay JE; Simon MC
    Int J Hematol; 2012 May; 95(5):464-70. PubMed ID: 22539362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hypoxia in the hallmarks of human cancer.
    Ruan K; Song G; Ouyang G
    J Cell Biochem; 2009 Aug; 107(6):1053-62. PubMed ID: 19479945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting.
    Dewhirst MW
    Cancer Res; 2007 Feb; 67(3):854-5. PubMed ID: 17283112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ever-expanding role of HIF in tumour and stromal biology.
    LaGory EL; Giaccia AJ
    Nat Cell Biol; 2016 Apr; 18(4):356-65. PubMed ID: 27027486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia in the intestine or solid tumors: a beneficial or deleterious alarm signal?
    Shehade H; Oldenhove G; Moser M
    Eur J Immunol; 2014 Sep; 44(9):2550-7. PubMed ID: 25043839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of HIF prolyl hydroxylases in tumour growth.
    Jokilehto T; Jaakkola PM
    J Cell Mol Med; 2010 Apr; 14(4):758-70. PubMed ID: 20178464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
    Seo J; Yun JE; Kim SJ; Chun YS
    Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factors as key regulators of tumor inflammation.
    Mamlouk S; Wielockx B
    Int J Cancer; 2013 Jun; 132(12):2721-9. PubMed ID: 23055435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
    Martínez-Sánchez G; Giuliani A
    J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of hypoxia-inducible factors in tumorigenesis.
    Rankin EB; Giaccia AJ
    Cell Death Differ; 2008 Apr; 15(4):678-85. PubMed ID: 18259193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.